178 related articles for article (PubMed ID: 20427139)
21. MR imaging of hepatocellular carcinoma: relationship between lesion size and imaging findings, including signal intensity and dynamic enhancement patterns.
van den Bos IC; Hussain SM; Dwarkasing RS; Hop WC; Zondervan PE; de Man RA; IJzermans JN; Walker CW; Krestin GP
J Magn Reson Imaging; 2007 Dec; 26(6):1548-55. PubMed ID: 17968956
[TBL] [Abstract][Full Text] [Related]
22. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
[TBL] [Abstract][Full Text] [Related]
23. Double-contrast MRI in patients with cirrhosis.
Guiu B; Loffroy R; Cercueil JP
AJR Am J Roentgenol; 2008 Aug; 191(2):W78. PubMed ID: 18647893
[No Abstract] [Full Text] [Related]
24. Capsule of hepatocellular carcinoma: where and how does the capsule show enhancement?
Itai Y
Radiology; 1999 Feb; 210(2):577-9. PubMed ID: 10207449
[No Abstract] [Full Text] [Related]
25. Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumine.
Filippone A; Blakeborough A; Breuer J; Grazioli L; Gschwend S; Hammerstingl R; Heinz-Peer G; Kittner T; Laghi A; Leen E; Lencioni R; Lucidarme O; Remplik P; Robinson PJ; Ruehm SG; Schaefer F; Stoupis C; Tombach B; Valette PJ; Zech CJ; Huppertz A
J Magn Reson Imaging; 2010 Feb; 31(2):356-64. PubMed ID: 20099349
[TBL] [Abstract][Full Text] [Related]
26. Paradoxical high signal intensity of hepatocellular carcinoma in the hepatobiliary phase of Gd-EOB-DTPA enhanced MRI: initial experience.
Lee SA; Lee CH; Jung WY; Lee J; Choi JW; Kim KA; Park CM
Magn Reson Imaging; 2011 Jan; 29(1):83-90. PubMed ID: 20832227
[TBL] [Abstract][Full Text] [Related]
27. Detection of hepatic metastases from colorectal cancer: prospective evaluation of gray scale US versus SonoVue® low mechanical index real time-enhanced US as compared with multidetector-CT or Gd-BOPTA-MRI.
Cantisani V; Ricci P; Erturk M; Pagliara E; Drudi F; Calliada F; Mortele K; D'Ambrosio U; Marigliano C; Catalano C; Marin D; Di Seri M; Longo F; Passariello R
Ultraschall Med; 2010 Oct; 31(5):500-5. PubMed ID: 20408122
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of patients with elevated α-fetoprotein level and initial negative findings at MR imaging.
Kim BS; Hayashi PH; Kim SH; Angthong W; Srirattanapong S; Woosley JT; Semelka RC
Radiology; 2013 Jul; 268(1):109-19. PubMed ID: 23392426
[TBL] [Abstract][Full Text] [Related]
29. Double-dose gadoxetic Acid-enhanced magnetic resonance imaging in patients with chronic liver disease.
Motosugi U; Ichikawa T; Sano K; Sou H; Onohara K; Muhi A; Kitamura T; Amemiya F; Enomoto N; Matsuda M; Asakawa M; Fujii H; Araki T
Invest Radiol; 2011 Feb; 46(2):141-5. PubMed ID: 21139506
[TBL] [Abstract][Full Text] [Related]
30. [Dynamic MRI].
Araki T; Ichikawa T; Nakajima H
Nihon Rinsho; 2001 Oct; 59 Suppl 6():292-5. PubMed ID: 11761959
[No Abstract] [Full Text] [Related]
31. The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging.
Burke C; Alexander Grant L; Goh V; Griffin N
Semin Ultrasound CT MR; 2013 Feb; 34(1):44-53. PubMed ID: 23395317
[TBL] [Abstract][Full Text] [Related]
32. Comparison of different tumor response criteria in patients with hepatocellular carcinoma after systemic therapy with the multikinase inhibitor sorafenib.
Spira D; Fenchel M; Lauer UM; Claussen CD; Gregor M; Bitzer M; Horger M
Acad Radiol; 2011 Jan; 18(1):89-96. PubMed ID: 20926315
[TBL] [Abstract][Full Text] [Related]
33. Hepatocellular carcinoma lesion characterization: single-institution clinical performance review of multiphase gadolinium-enhanced MR imaging--comparison to prior same-center results after MR systems improvements.
Becker-Weidman DJ; Kalb B; Sharma P; Kitajima HD; Lurie CR; Chen Z; Spivey JR; Knechtle SJ; Hanish SI; Adsay NV; Farris AB; Martin DR
Radiology; 2011 Dec; 261(3):824-33. PubMed ID: 21969663
[TBL] [Abstract][Full Text] [Related]
34. Retrospective respiratory triggering renal perfusion MRI.
Attenberger UI; Sourbron SP; Michaely HJ; Reiser MF; Schoenberg SO
Acta Radiol; 2010 Dec; 51(10):1163-71. PubMed ID: 21062133
[TBL] [Abstract][Full Text] [Related]
35. Infiltrative hepatocellular carcinoma: comparison of MRI sequences for lesion conspicuity.
Rosenkrantz AB; Lee L; Matza BW; Kim S
Clin Radiol; 2012 Dec; 67(12):e105-11. PubMed ID: 23026725
[TBL] [Abstract][Full Text] [Related]
36. Hepatocellular carcinoma with bile duct tumor thrombi: correlation of magnetic resonance imaging features to histopathologic manifestations.
Liu Q; Chen J; Li H; Liang B; Zhang L; Hu T
Eur J Radiol; 2010 Oct; 76(1):103-9. PubMed ID: 19501994
[TBL] [Abstract][Full Text] [Related]
37. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
[TBL] [Abstract][Full Text] [Related]
38. MultiHance: help or hype?
Bartolozzi C; Spinazzi A
J Comput Assist Tomogr; 1999 Nov; 23 Suppl 1():S151-9. PubMed ID: 10608411
[TBL] [Abstract][Full Text] [Related]
39. [Secondary liver involvement in multiple myeloma: diagnostic imaging with magnetic resonance tomography (MRI)].
Ajaj W; Yang F; Ruehm SG
Rofo; 2003 May; 175(5):706-7. PubMed ID: 12743867
[No Abstract] [Full Text] [Related]
40. Serial MR imaging of small arterially-enhancing liver lesions in patients with chronic liver disease.
Korpraphong P; Leyendecker JR; Hildebolt CF; Narra V; Bae KT; Brown JJ
J Med Assoc Thai; 2009 Apr; 92(4):548-55. PubMed ID: 19374308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]